Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.1199 (-23.06%)
Nov 9, 2026, 2:00 PM EST

Cell Source Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
281518304364
Market Cap Growth
46.56%-14.99%-40.09%-30.67%-32.39%119.45%
Enterprise Value
382628375068
Last Close Price
0.520.350.460.851.282.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
--0.82-1.15-2.37-4.40-8.04

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.54-0.57-0.60-0.63-0.66-0.60
Net Debt / Equity Ratio
-0.54-0.57-0.60-0.61-0.65-0.57
Net Debt / FCF Ratio
-3.48-3.91-3.99-2.45-1.89-1.64
Quick Ratio
00.010.000.020.010.03
Current Ratio
0.010.020.010.030.030.05
Return on Assets (ROA)
-1233.46%-996.60%-864.18%-721.27%-655.68%-801.86%
Return on Capital Employed (ROCE)
18.40%20.70%26.80%33.00%40.90%45.80%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-35.58%-29.57%-29.64%-17.25%-12.66%-7.13%
FCF Yield
-10.90%-17.59%-13.08%-10.47%-7.82%-4.34%
Buyback Yield / Dilution
-11.27%-10.81%-8.47%-5.19%-13.81%-2.72%